XML 43 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Valuation (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule Of Financial Instruments
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
90,000

 
$

 
$

 
$
90,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
868,345

 
$
29,622

 
$
897,967

U.S. Treasury securities
 

 
5,419

 

 
5,419

Private label residential mortgage-backed securities
 

 
53,525

 
90,083

 
143,608

Private label commercial mortgage-backed securities
 

 

 
43,268

 
43,268

Commercial mortgage loans
 

 

 
61,129

 
61,129

Residential mortgage loans
 

 

 
84,290

 
84,290

Collateralized loan obligations
 

 

 
44,956

 
44,956

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
114,472

 
114,472

Corporate debt
 

 
55,091

 
25,004

 
80,095

Real estate owned
 

 

 
3,349

 
3,349

Corporate equity investments
 
4,396

 

 
22,077

 
26,473

Total investments, at fair value
 
4,396

 
982,380

 
518,250

 
1,505,026

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
5,326

 
5,326

Credit default swaps on corporate bond indices
 

 
2,744

 

 
2,744

Credit default swaps on corporate bonds
 

 
2,360

 

 
2,360

Credit default swaps on asset-backed indices
 

 
16,713

 

 
16,713

Interest rate swaps
 

 
8,102

 

 
8,102

Total return swaps
 

 

 
155

 
155

Options
 
42

 
2

 

 
44

Futures
 
29

 

 

 
29

Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Forwards
 
$

 
$
16

 
$

 
$
16

Warrants
 

 

 
106

 
106

Total financial derivatives–assets, at fair value
 
71

 
29,937

 
5,587

 
35,595

Repurchase agreements
 

 
184,819

 

 
184,819

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
4,467

 
$
1,197,136

 
$
523,837

 
$
1,725,440

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(404,728
)
 
$

 
$
(404,728
)
Government debt
 

 
(132,442
)
 

 
(132,442
)
Corporate debt
 

 
(39,572
)
 

 
(39,572
)
Common stock
 
(8,154
)
 

 

 
(8,154
)
Total investments sold short, at fair value
 
(8,154
)
 
(576,742
)
 

 
(584,896
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(2,840
)
 

 
(2,840
)
Credit default swaps on corporate bonds
 

 
(6,654
)
 

 
(6,654
)
Credit default swaps on asset-backed indices
 

 
(2,899
)
 

 
(2,899
)
Credit default swaps on asset-backed securities
 

 

 
(256
)
 
(256
)
Interest rate swaps
 

 
(5,162
)
 

 
(5,162
)
Total return swaps
 

 
(55
)
 
(249
)
 
(304
)
Futures
 
(69
)
 

 

 
(69
)
Forwards
 

 
(472
)
 

 
(472
)
Mortgage loan purchase commitments
 

 
(31
)
 

 
(31
)
Total financial derivatives–liabilities, at fair value
 
(69
)
 
(18,113
)
 
(505
)
 
(18,687
)
Total investments sold short, and financial derivatives–liabilities, at fair value
 
$
(8,223
)
 
$
(594,855
)
 
$
(505
)
 
$
(603,583
)
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at March 31, 2017:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
40,000

 
$

 
$

 
$
40,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,065,009

 
$
29,425

 
$
1,094,434

U.S. Treasury securities
 

 
36,488

 

 
36,488

Private label residential mortgage-backed securities
 

 
41,135

 
80,332

 
121,467

Private label commercial mortgage-backed securities
 

 

 
41,300

 
41,300

Commercial mortgage loans
 

 

 
62,508

 
62,508

Residential mortgage loans
 

 

 
112,650

 
112,650

Collateralized loan obligations
 

 

 
70,561

 
70,561

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
114,278

 
114,278

Corporate debt
 

 
95,210

 
59,609

 
154,819

Real estate owned
 

 

 
25,390

 
25,390

Corporate equity investments
 
2,837

 

 
27,481

 
30,318

Total investments, at fair value
 
2,837

 
1,237,842

 
623,534

 
1,864,213

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
5,828

 
5,828

Credit default swaps on corporate bond indices
 

 
832

 

 
832

Credit default swaps on corporate bonds
 

 
4,577

 

 
4,577

Credit default swaps on asset-backed indices
 

 
10,653

 

 
10,653

Interest rate swaps
 

 
7,937

 

 
7,937

Options
 
66

 
1

 

 
67

Forwards
 

 
13

 

 
13

Total financial derivatives–assets, at fair value
 
66

 
24,013

 
5,828

 
29,907

Repurchase agreements
 

 
293,802

 

 
293,802

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
2,903

 
$
1,555,657

 
$
629,362

 
$
2,187,922

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(523,620
)
 
$

 
$
(523,620
)
Government debt
 

 
(165,080
)
 

 
(165,080
)
Corporate debt
 

 
(89,466
)
 

 
(89,466
)
Common stock
 
(2,154
)
 

 

 
(2,154
)
Total investments sold short, at fair value
 
(2,154
)
 
(778,166
)
 

 
(780,320
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(2,911
)
 

 
(2,911
)
Credit default swaps on corporate bonds
 

 
(10,638
)
 

 
(10,638
)
Credit default swaps on asset-backed indices
 

 
(2,255
)
 

 
(2,255
)
Credit default swaps on asset-backed securities
 

 

 
(218
)
 
(218
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Interest rate swaps
 
$

 
$
(4,710
)
 
$

 
$
(4,710
)
Total return swaps
 

 
(11
)
 

 
(11
)
Futures
 
(57
)
 

 

 
(57
)
Forwards
 

 
(138
)
 

 
(138
)
Total financial derivatives–liabilities, at fair value
 
(57
)
 
(20,663
)
 
(218
)
 
(20,938
)
Total investments sold short and financial derivatives–liabilities, at fair value
 
$
(2,211
)
 
$
(798,829
)
 
$
(218
)
 
$
(801,258
)

Schedule Of Significant Unobservable Inputs, Qualitative Information
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of March 31, 2017:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
41,034

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
1.94

 
$
115.30

 
$
70.74

Collateralized loan obligations
 
62,529

 
Market Quotes
 
Non Binding Third-Party Valuation
 
11.00

 
380.00

 
106.17

Corporate debt and non-exchange traded corporate equity
 
57,671

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.59

 
102.46

 
91.97

Private label commercial mortgage-backed securities
 
23,401

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.40

 
81.30

 
40.29

Agency interest only residential mortgage-backed securities
 
24,890

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.95

 
21.31

 
11.97

Private label residential mortgage-backed securities
 
39,298

 
Discounted Cash Flows
 
Yield
 
2.3
%
 
27.3
%
 
12.4
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
84.5
%
 
7.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.5
%
 
51.3
%
 
44.1
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.0
%
 
52.4
%
 
44.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.4
%
 
4.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
17,899

 
Discounted Cash Flows
 
Yield
 
11.6
%
 
59.6
%
 
22.4
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.4
%
 
5.3
%
 
1.6
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.8
%
 
17.1
%
 
6.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
77.6
%
 
97.8
%
 
91.9
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt
 
6,320

 
Discounted Cash Flows
 
Yield
 
16.1
%
 
16.1
%
 
16.1
%
Collateralized loan obligations
 
8,032

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
50.8
%
 
18.1
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
2.9
%
 
67.1
%
 
42.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.1
%
 
47.2
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
33.2
%
 
8.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
16.6
%
 
52.7
%
 
38.5
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Consumer loans and asset-backed securities backed by consumer loans
 
$
114,278

 
Discounted Cash Flows
 
Yield
 
8.9
%
 
19.0
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
48.8
%
 
35.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
97.6
%
 
8.5
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
100.0
%
 
55.8
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
54,768

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
15.4
%
 
10.8
%
Non-performing commercial mortgage loans and commercial real estate owned
 
31,910

 
Discounted Cash Flows
 
Yield
 
7.7
%
 
20.0
%
 
13.7
%
 
 
 
 
 
 
Months to Resolution
 
3.0

 
39.1

 
18.6

Performing residential mortgage loans
 
104,406

 
Discounted Cash Flows
 
Yield
 
1.7
%
 
17.4
%
 
6.5
%
Non-performing residential mortgage loans and residential real estate owned
 
9,464

 
Discounted Cash Flows
 
Yield
 
2.0
%
 
75.6
%
 
14.6
%
 
 
 
 
 
 
Months to Resolution
 
4.2

 
185.2

 
47.0

Credit default swaps on asset-backed securities
 
5,610

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.5
%
 
29.6
%
 
22.2
%
 
 
 
 
 
 
Projected Collateral Losses
 
15.5
%
 
28.2
%
 
22.8
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
5.1
%
 
14.8
%
 
9.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
43.3
%
 
49.0
%
 
45.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
 
3,099

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
 
Expected Holding Period (Months)
 
1.9

 
1.9

 
1.9

Agency interest only residential mortgage-backed securities
 
4,535

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(1)
 
371

 
1,950

 
711

 
 
 
 
 
 
Projected Collateral Prepayments
 
9.7
%
 
100.0
%
 
64.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
11.3
%
 
1.1
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.3
%
 
34.9
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entity
 
2,500

 
Enterprise Value
 
Equity Multiple(2)
 
1.4x
 
1.4x
 
1.4x
Non-exchange traded preferred equity investment in mortgage-related entity
 
17,500

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A

(1)
Shown in basis points.
(2)
Represent an estimation of where market participants might value an enterprise.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2016:
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
 
$
47,024

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
2.00

 
$
101.02

 
$
67.51

Collateralized loan obligations
 
37,517

 
Market Quotes
 
Non Binding Third-Party Valuation
 
9.42

 
100.25

 
83.36

Corporate debt and non-exchange traded corporate equity
 
19,017

 
Market Quotes
 
Non Binding Third-Party Valuation
 
1.88

 
102.25

 
87.14

Private label commercial mortgage-backed securities
 
27,283

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.17

 
77.75

 
40.88

Agency interest only residential mortgage-backed securities
 
23,322

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.47

 
20.17

 
11.65

Total return swaps
 
(94
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
98.25

 
99.50

 
98.77

Private label residential mortgage-backed securities
 
43,059

 
Discounted Cash Flows
 
Yield
 
0.6
%
 
20.5
%
 
11.0
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
81.0
%
 
10.0
%
 
 
 
 
 
 
Projected Collateral Losses
 
1.4
%
 
51.2
%
 
41.4
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.4
%
 
53.6
%
 
41.2
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
90.7
%
 
7.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
 
15,985

 
Discounted Cash Flows
 
Yield
 
8.8
%
 
57.0
%
 
23.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.1
%
 
5.3
%
 
2.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
0.9
%
 
20.5
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
77.8
%
 
99.0
%
 
87.1
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
 
10,080

 
Discounted Cash Flows
 
Yield
 
19.7
%
 
19.7
%
 
19.7
%
Collateralized loan obligations
 
7,439

 
Discounted Cash Flows
 
Yield
 
11.2
%
 
50.3
%
 
20.5
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
11.4
%
 
55.2
%
 
45.5
%
 
 
 
 
 
 
Projected Collateral Losses
 
4.5
%
 
28.3
%
 
10.7
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
27.2
%
 
8.6
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
29.8
%
 
51.5
%
 
35.2
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
 
114,472

 
Discounted Cash Flows
 
Yield
 
8.5
%
 
25.0
%
 
10.9
%
 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
45.4
%
 
25.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
3.3
%
 
97.4
%
 
9.9
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
87.7
%
 
64.5
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
 
32,557

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
17.2
%
 
11.6
%
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
 
Min
 
Max
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
 
$
30,222

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
27.8
%
 
16.3
%
 
 
 
 
 
 
Months to Resolution
 
3.0

 
39.1

 
19.5

Performing residential mortgage loans
 
78,576

 
Discounted Cash Flows
 
Yield
 
5.0
%
 
13.5
%
 
6.6
%
Non-performing residential mortgage loans and residential real estate owned
 
7,413

 
Discounted Cash Flows
 
Yield
 
5.8
%
 
39.9
%
 
9.7
%
 
 
 
 
 
 
Months to Resolution
 
1.8

 
162.9

 
41.9

Credit default swaps on asset-backed securities
 
5,070

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.3
%
 
29.8
%
 
22.7
%
 
 
 
 
 
 
Projected Collateral Losses
 
15.3
%
 
27.6
%
 
22.2
%
 
 
 
 
 
 
Projected Collateral Recoveries
 
4.7
%
 
15.3
%
 
8.7
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
43.2
%
 
50.2
%
 
46.4
%
 
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
 
3,090

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
 
Expected Holding Period (Months)
 
2.9

 
2.9

 
2.9

Agency interest only residential mortgage-backed securities
 
6,300

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
142

 
2,831

 
568

 
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
100.0
%
 
62.6
%
 
 
 
 
 
 
Projected Collateral Losses
 
0.0
%
 
15.7
%
 
1.0
%
 
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
88.1
%
 
36.4
%
 
 


 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entity
 
2,500

 
Enterprise Value
 
Equity Multiple(3)
 
1.3x

 
1.3x

 
1.3x

Non-exchange traded preferred equity investment in mortgage-related entity
 
12,500

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
Fair Value Measurement Using Significant Unobservable Inputs
The tables below include a roll-forward of the Company's financial instruments for the three month periods ended March 31, 2017 and 2016 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended March 31, 2017
(In thousands)
Ending
Balance as of 
December 31, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2017
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
29,622

 
$
(2,592
)
 
$
(35
)
 
$
228

 
$
2,202

 
$

 
$

 
$

 
$
29,425

Private label residential mortgage-backed securities
90,083

 
1,478

 
(703
)
 
2,893

 
8,049

 
(19,527
)
 
3,473

 
(5,414
)
 
80,332

Private label commercial mortgage-backed securities
43,268

 
356

 
342

 
1,411

 

 
(4,077
)
 

 

 
41,300

Commercial mortgage loans
61,129

 
530

 
337

 
1,206

 
23,045

 
(23,739
)
 

 

 
62,508

Residential mortgage loans
84,290

 
140

 
(51
)
 
404

 
34,138

 
(6,271
)
 

 

 
112,650

Collateralized loan obligations
44,956

 
(1,183
)
 
920

 
2,532

 
38,712

 
(15,376
)
 

 

 
70,561

Consumer loans and asset-backed securities backed by consumer loans
114,472

 
(3,057
)
 
(552
)
 
646

 
24,418

 
(21,649
)
 

 

 
114,278

Corporate debt
25,004

 
100

 
331

 
158

 
47,094

 
(13,078
)
 

 

 
59,609

Real estate owned
3,349

 

 
60

 
106

 
24,157

 
(2,282
)
 

 

 
25,390

Corporate equity investments
22,077

 

 

 
462

 
5,000

 
(58
)
 

 

 
27,481

Total investments, at fair value
518,250

 
(4,228
)
 
649

 
10,046

 
206,815

 
(106,057
)
 
3,473

 
(5,414
)
 
623,534

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
5,326

 

 
37

 
502

 
59

 
(96
)
 

 

 
5,828

Total return swaps
155

 

 
157

 
(155
)
 

 
(157
)
 

 

 

Warrants
106

 

 
(100
)
 
(6
)
 

 

 

 

 

Total financial derivatives– assets, at fair value
5,587

 

 
94

 
341

 
59

 
(253
)
 

 

 
5,828

Total investments and financial derivatives–assets, at fair value
$
523,837

 
$
(4,228
)
 
$
743

 
$
10,387

 
$
206,874

 
$
(106,310
)
 
$
3,473

 
$
(5,414
)
 
$
629,362

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(256
)
 
$

 
$
(446
)
 
$
466

 
$
18

 
$

 
$

 
$

 
$
(218
)
Total return swaps
(249
)
 

 
(206
)
 
248

 
283

 
(76
)
 

 

 

Total financial derivatives– liabilities, at fair value
(505
)
 

 
(652
)
 
714

 
301

 
(76
)
 

 

 
(218
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2017, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2017. For Level 3 financial instruments held by the Company at March 31, 2017, change in net unrealized gain (loss) of $6.9 million, $0.5 million, and $0.5 million for the three month period ended March 31, 2017 relate to investments, financial derivatives–assets, and financial derivatives–liabilities, respectively.
During the three month period ended March 31, 2017, the Company transferred $5.4 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and/or similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the three month period ended March 31, 2017, the Company transferred $3.5 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2016, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Three Month Period Ended March 31, 2016
(In thousands)
Ending
Balance as of December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(2,057
)
 
$
(9
)
 
$
(546
)
 
$

 
$

 
$

 
$

 
$
22,306

Private label residential mortgage-backed securities
116,435

 
605

 
313

 
(1,709
)
 
5,731

 
(4,943
)
 
12,070

 
(15,120
)
 
113,382

Private label commercial mortgage-backed securities
34,145

 
455

 
322

 
(3,000
)
 
7,844

 
(4,416
)
 

 

 
35,350

Commercial mortgage loans
66,399

 
546

 
183

 
893

 
13,424

 
(25,080
)
 

 

 
56,365

Residential mortgage loans
22,089

 
107

 
108

 
275

 
14,965

 
(1,964
)
 

 

 
35,580

Collateralized loan obligations
45,974

 
(927
)
 
1,080

 
272

 

 
(11,984
)
 

 

 
34,415

Consumer loans and asset-backed securities backed by consumer loans
115,376

 
(2,882
)
 

 
105

 
51,910

 
(20,655
)
 

 

 
143,854

Corporate debt
27,028

 
113

 
(20
)
 
(3,975
)
 
2,967

 
(1,561
)
 

 

 
24,552

Real estate owned
12,522

 

 
260

 
1,419

 
9,788

 
(2,146
)
 

 

 
21,843

Corporate equity investments
22,088

 

 
(130
)
 
(1,228
)
 
3,927

 
(58
)
 

 

 
24,599

Total investments, at fair value
486,974

 
(4,040
)
 
2,107

 
(7,494
)
 
110,556

 
(72,807
)
 
12,070

 
(15,120
)
 
512,246

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
6,332

 
$

 
$
91

 
$
(105
)
 
$
36

 
$
(127
)
 
$

 
$

 
$
6,227

Total return swaps
85

 

 
(3,515
)
 
989

 
3,568

 
(53
)
 

 

 
1,074

Warrants
150

 

 
(50
)
 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
6,567

 

 
(3,474
)
 
884

 
3,604

 
(180
)
 

 

 
7,401

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(4,040
)
 
$
(1,367
)
 
$
(6,610
)
 
$
114,160

 
$
(72,987
)
 
$
12,070

 
$
(15,120
)
 
$
519,647

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2016
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
1

 
$
360

 
$
(249
)
 
$
887

 
$
(3,580
)
 
$

 
$

 
$
(3,029
)
Total investments sold short, at fair value
(448
)
 
1

 
360

 
(249
)
 
887

 
(3,580
)
 

 

 
(3,029
)
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(221
)
 
$

 
$
(16
)
 
$
1

 
$

 
$
16

 
$

 
$

 
$
(220
)
Total return swaps
(4,662
)
 

 
(2,251
)
 
3,988

 
2,337

 
(87
)
 

 

 
(675
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(2,267
)
 
3,989

 
2,337

 
(71
)
 

 

 
(895
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
212

 

 

 

 

 
(616
)
Total guarantees
(828
)
 

 

 
212

 

 

 

 

 
(616
)
Total financial derivatives– liabilities and guarantees, at fair value
$
(6,159
)
 
$
1

 
$
(1,907
)
 
$
3,952

 
$
3,224

 
$
(3,651
)
 
$

 
$

 
$
(4,540
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2016. For Level 3 financial instruments held by the Company at March 31, 2016, change in net unrealized gain (loss) of $(7.7) million, $3.6 million, $0.6 million, and $0.2 million, for the three month period ended March 31, 2016 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
During the three month ended March 31, 2016, the Company transferred $15.1 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and/or similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the three month period ended March 31, 2016, the Company transferred $12.1 million of non-Agency RMBS from Level 2 to Level 3. Following December 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
There were no transfers of financial instruments between Level 1 and Level 2 during the three month periods ended March 31, 2017 and 2016.